vasoactive-intestinal-peptide and Kidney-Diseases

vasoactive-intestinal-peptide has been researched along with Kidney-Diseases* in 3 studies

Reviews

2 review(s) available for vasoactive-intestinal-peptide and Kidney-Diseases

ArticleYear
Clinical relevance of regulatory gastrointestinal peptides.
    Clinical biochemistry, 1984, Volume: 17, Issue:2

    The application of radioimmunoassay of insulin, C-peptide, gastrin, glucagon, vasoactive intestinal polypeptides (VIP), somatostatin, human pancreatic polypeptides (hPP), substance P and neurotensin to detect endocrine tumors of the pancreas and other organ systems is undoubtedly important in the clinical management of patients suspected of having tumors that secrete these hormones. Radioimmunoassays of the above gut peptides have certain degrees of specificity and sensitivity; however, there are several factors that need to be considered in the interpretation of results since heterogeneity of molecular forms does occur and the varied radioimmunoassay techniques use different antibodies that may yield different results. It is, therefore, important that each laboratory establish its own normal values, determine the molecular species that each assay is detecting, and also determine the false positivity of the methodology. The same endocrine tumor may contain and secrete several detectable peptides, but the syndrome may relate to only one peptide. Although the simultaneous measurement of multiple peptides in patients with benign gastrointestinal disease has yielded information that contributes to our understanding of the complexities of gut neuroendocrine interaction, the pathophysiological role of gut peptides and their clinical relevance need further evaluation.

    Topics: Animals; Diagnosis, Differential; Digestion; Food; Gastrins; Gastrointestinal Diseases; Gastrointestinal Hormones; Humans; Kidney Diseases; Pancreatic Neoplasms; Pancreatic Polypeptide; Radioimmunoassay; Vagus Nerve; Vasoactive Intestinal Peptide; Vipoma; Zollinger-Ellison Syndrome

1984
[Renal function in chronic hepatopathies].
    Minerva medica, 1978, Oct-06, Volume: 69, Issue:47

    Topics: Endotoxins; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Kinins; Liver Diseases; Natriuresis; Plasma Volume; Prolactin; Prostaglandins; Vasoactive Intestinal Peptide; Vasoconstriction; Vasomotor System

1978

Other Studies

1 other study(ies) available for vasoactive-intestinal-peptide and Kidney-Diseases

ArticleYear
[Vasoactive intestinal polypeptide (V.I.P)].
    Acta gastroenterologica Latinoamericana, 1978, Volume: 8, Issue:2

    Topics: Adenoma, Islet Cell; Animals; APUD Cells; Biliary Tract; Cholera; Dehydration; Diarrhea; Gastric Juice; Gastrointestinal Hormones; Gastrointestinal Motility; Humans; Hypokalemia; In Vitro Techniques; Kidney Diseases; Metabolism; Neurotransmitter Agents; Pancreatic Neoplasms; Respiration; Vasoactive Intestinal Peptide

1978